Supplementary Data from Selinexor Combined with Ibrutinib Demonstrates Tolerability and Safety in Advanced B-Cell Malignancies: A Phase I Study

Authors :: Jennifer A. Woyach
John C. Byrd
Rosa Lapalombella
Hank Lockman
Samantha M. Jaglowski
Seema Bhat
Kerry A. Rogers
Renee Vadeboncoeur
Harsh Shah
Boyu Hu
Sharyn Baker
Qiang Fu
Casey B. Cempre
Daniel Canfield
Janek S. Walker
Amy S. Ruppert
Ying Huang
Deborah M. Stephens
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Supplementary Data from Selinexor Combined with Ibrutinib Demonstrates Tolerability and Safety in Advanced B-Cell Malignancies: A Phase I Study

Tools